Enhancement of apoptosis of THP-1 cells infected with Mycobacterium tuberculosis by inhalable microparticles and relevance to bactericidal activity

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 10, 2007, Pages 3740-3742

  Yadav, Awadh Bihari ^a   Misra, Amit ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PHORBOL 13 ACETATE 12 MYRISTATE; PURINE P2 RECEPTOR; RIFABUTIN;

APOPTOSIS; ARTICLE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

ANTITUBERCULAR AGENTS; APOPTOSIS; CASPASE 3; CELL LINE; FLOW CYTOMETRY; HUMANS; ISONIAZID; MYCOBACTERIUM TUBERCULOSIS; NANOPARTICLES; PHAGOCYTOSIS; RECEPTORS, PURINERGIC P2; RIFABUTIN; TETRADECANOYLPHORBOL ACETATE; TUBERCULOSIS;

EID: 34948900313     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00925-07     Document Type: Article

References (18)

1. Cynamon, M. H., Y. Zhang, T. Harpster, S. Cheng, and M. S. DeStefano. 1999. High-dose isoniazid therapy for isoniazid-resistant murine Mycobacterium tuberculosis infection. Antimicrob. Agents Chemother. 43:2922-2924.
2. Fratazzi, C., R. D. Arbeit, C. Carini, and H. G. Remold. 1997. Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. J. Immunol. 158:4320-4327.
3. Gan, H., X. He, L. Duan, E. Mirabile-Levens, H. Kornfeld, and H. G. Remold. 2005. Enhancement of antimycobacterial activity of macrophages by stabilization of inner mitochondrial membrane potential. J. Infect. Dis. 191: 1292-1300.
4. Hestvik, A. L., Z. Hmama, and Y. Av-Gay. 2005. Mycobacterial manipulation of the host cell. FEMS Microbiol. Rev. 29:1041-1050.
5. Kanuka, H., S. Hisahara, K. Sawamoto, S. Shoji, H. Okano, and M. Miura. 1999. Proapoptotic activity of Caenorhabditis elegans CED-4 protein in Drosophila: implicated mechanisms for caspase activation. Proc. Natl. Acad. Sci. USA 96:145-150.
6. Langton, M. E., and R. L. Cowie. 1985. Failure of a prothionamide-containing oral antituberculosis regimen. S. Afr. Med. J. 68:881.
7. Lee, J., H. G. Remold, M. H. Ieong, and H. Kornfeld. 2006. Macrophage apoptosis in response to high intracellular burden of Mycobacterium tuberculosis is mediated by a novel caspase-independent pathway. J. Immunol. 176:4267-4274.
8. Muttil, P., J. Kaur, K. Kumar, A. B. Yadav, R. Sharma, and A. Misra. 4 July 2007, posting date. Inhalable microparticles containing large payload of anti-tuberculosis drugs. Eur. J. Pharm. Sci. doi:10.1016/j.cjps.2007. 06.006.
9. O'Hara, P., and A. J. Hickey. 2000. Respirable PLGA microspheres containing rifamycin for the treatment of tuberculosis: manufacture and characterization. Pharm. Res. 17:955-961.
10. Pandey, R., and G. K. Khuller. 2005. Antitubercular inhaled therapy: opportunities, progress and challenges. J. Antimicrob. Chemother. 55:430-435.
11. Prior, S., B. Gander, N. Blarer, H. Merkle, M. Subira, J. Irache, and C. Gamazo. 2002. In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres. Eur. J. Pharm. Sci. 15:197-207.
12. Rajavelu, P., and S. D. Das. 2007. A correlation between phagocytosis and apoptosis in THP-1 cells infected with prevalent strains of Mycobacterium tuberculosis. Microbiol. Immunol. 51:201-210.
13. Riendeau, C. J., and H. Kornfeld. 2003. THP-1 cell apoptosis in response to mycobacterial infaction. Infect. Immun. 71:254-259.
14. Schnyder, J., and M. Baggiolini. 1978. Role of phagocytosis in the activation of macrophages. J. Exp. Med. 148:1449-1457.
15. Sharma, R., P. Muttil, A. B. Yadav, S. K. Rath, V. K. Bajpai, U. Mani, and A. Misra. 2007. Uptake of inhalable microparticles affects defence responses of macrophages infected with Mycobacterium tuberculosis H37Ra. J. Antimicrob. Chemother. 59:499-506.
16. Sharma, R., D. Saxena, A. K. Dwivedi, and A. Misra. 2001. Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis. Pharm. Res. 18:1405-1410.
17. Suarez, S., P. O'Hara, M. Kazantseva, C. E. Newcomer, R. Hopfer, D. N. McMurray, and A. J. Hickey. 2001. Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model. Pharm. Res. 18:1315-1319.
18. Wilson, H. L., R. W. Varcoe, L. Stokes, K. L. Holland, S. E. Francis, S. K. Dower, A. Surprenant, and D. C. Crossman. 2007. P2X receptor characterization and IL-1/IL-1Ra release from human endothelial cells. Br. J. Pharmacol. 151:115-127.